ALL
-
-
Nov 01, 2023 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Dosage and Administration of Famciclovir Tablets 250mg “KYOSOMIRAI” and Famciclovir Tablets 250mg “KMP” for KYOSOMIRAI PHARMA(104 KB)
-
-
Oct 31, 2023 performance
-
-
performance
-
Notice Regarding Revision of the Earnings Forecasts for the First Half of Fiscal Year Ending March 2024(82 KB)
-
-
Oct 24, 2023 other
-
-
other
-
Notice of “Proposal for Business Continuity Plan in the Supply of Pharmaceuticals” by the Study Group for the Establishment of BCP System(114 KB)
-
-
Oct 24, 2023 other
-
-
other
-
Notice of Joint Disaster Prevention Drill with the Ground Self-Defense Force to Prepare for Nankai Trough Megaquake(116 KB)
-
-
Oct 03, 2023 stock
-
-
stock
-
Notice Regarding the Status of Acquisition of Company Stocks(123 KB)
-
-
Sep 15, 2023 stock
-
-
stock
-
Notice of Acquisition of Company Stock and Cancellation of Those Shares(155 KB)
-
-
Sep 15, 2023 M&A/partnership
-
-
M&A/partnership
-
Conclusion of Capital and Business Alliance with MICIN, Inc.(75 KB)
-
-
Sep 14, 2023 stock
-
-
stock
-
Notice of the Posting of a Gain on Sale of Investment Securities (Extraordinary Income)(84 KB)
-
-
Aug 18, 2023 stock
-
-
stock
-
Notice Regarding Completion of Payment Concerning Disposal of Treasury Stock as Restricted Stock Compensation(141 KB)
-
-
Aug 04, 2023 performance
-
-
performance
-
Consolidated Financial Results for the Three Months Ended June 30, 2023(369 KB)
-
-
Jul 20, 2023 stock
-
-
stock
-
Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation(199 KB)
-
-
Jul 19, 2023 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Indications, Dosage and Administration of ROSUVASTATIN TABLETS 2.5mg/5mg “KYOSOMIRAI”, ROSUVASTATIN OD TABLETS 2.5mg/5mg “KYOSOMIRAI”, ROSUVASTATIN TABLETS 2.5mg/5mg “KMP”, ROSUVASTATIN OD TABLETS 2.5mg/5mg “KMP” for KYOSOMIRAI PHARMA(117 KB)
-
-
Jun 29, 2023 corporate
-
-
corporate
-
Notice Regarding Executive Appointment(121 KB)
-
-
Jun 16, 2023 product/service
-
-
product/service
-
Notice Regarding Launch of 1 Ingredient / 3 Products of Generic Drugs for KYOSOMIRAI PHARMA(111 KB)
